Medindia

X

Reportlinker Adds The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis

Wednesday, December 16, 2009 Research News J E 4
Advertisement
NEW YORK, Dec. 15 Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis

http://www.reportlinker.com/p0168108/The-Future-of-Global-Vaccines---Market-Forecasts-to-2016-Stockpile-Analysis-Competitive-Benchmarking-and-Pipeline-Analysis.html

Summary

The author has released its latest research "The Future of Global Vaccines - Market Forecasts to 2015, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis", which provides insights on the global vaccines sales, volume and price forecasts to 2015. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global vaccines market. The report analyzes the markets for vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

Reasons to buy

The report will aid business development and marketing executives strategizing their product launches:

Table of Contents

1 Executive Summary

2 Table of Contents

2.1 List of Tables

2.2 List of Figures

3 Introduction

3.1 GBI Research Report Guidance

4 The Future of Global Vaccines: Market Overview

4.1 Vaccine Preventable Diseases

4.2 Vaccine Manufacturing Process

5 The Future of Global Vaccines: Global Market

5.1 Market Forecasts

5.1.1 Market Share by Disease Sectors

5.1.2 Market Share by Geography

5.2 Average Cost of Vaccination per Child

5.3 Target Population

5.3.1 Immunization Coverage

5.4 Unmet Needs

5.5 Market Trends

5.5.1 Immunization Programs

5.5.2 Public-Private Partnerships

5.5.3 Production Capacity

5.5.4 Reimbursements

5.6 Drivers

5.7 Barriers

6 The Future of Global Vaccines: The US Market

6.1 Market Overview

6.2 Market Forecasts

6.3 Average Cost of Vaccination per Child

6.4 Immunization Schedule

6.5 Regulatory Framework

6.6 Vaccine Procurement

6.7 Vaccine Stockpiling

7 The Future of Global Vaccines: European Market

7.1 Market Overview

7.2 Market Forecasts

7.3 Average Cost of Vaccination per Child

7.4 The United Kingdom

7.4.1 Immunization Schedule

7.4.2 Regulatory Framework

7.4.3 Vaccine Procurement

7.4.4 Vaccine Stockpiling

7.5 France

7.5.1 Immunization Schedule

7.5.2 Regulatory Framework

7.5.3 Vaccine Procurement

7.5.4 Vaccine Stockpiling

7.6 Germany

7.6.1 Immunization Schedule

7.6.2 Regulatory Framework

7.6.3 Vaccine Procurement

7.6.4 Vaccine Stockpiling

7.7 Italy

7.7.1 Immunization Schedule

7.7.2 Regulatory Framework

7.7.3 Vaccine Procurement

7.7.4 Vaccine Stockpiling

7.8 Spain

7.8.1 Immunization Schedule

7.8.2 Regulatory Framework

7.8.3 Vaccine Procurement

7.8.4 Vaccine Stockpiling

8 The Future of Global Vaccines: Rest of the World

8.1 Market Overview

8.2 Market Forecasts

8.3 Average Cost of Vaccination per Child

8.4 Immunization Schedule

8.5 Regulatory Framework

8.6 Vaccine Procurement

8.7 Vaccine Stockpiling

9 The Future of Global Vaccines: Global Rotavirus Vaccine Market

9.1 Market Overview

9.2 Market Forecasts

9.3 Average Cost of Vaccination

9.4 Immunization Schedule

9.5 Target Population

9.5.1 Immunization Coverage

9.6 Product Analysis

9.6.1 RotaTeq

9.6.2 Rotarix

9.7 Vaccine Pipeline Analysis

10 The Future of Global Vaccines: Global Pneumococcal Vaccine Market

10.1 Market Overview

10.2 Market Forecasts

10.3 Average Cost of Vaccination

10.4 Immunization Schedule

10.5 Target Population

10.5.1 Immunization Coverage

10.6 Product Analysis

10.6.1 Prevnar

10.6.2 Synflorix

10.7 Vaccine Pipeline Analysis

11 The Future of Global Vaccines: Global Human Papillomavirus Vaccine Market

11.1 Market Overview

11.2 Market Forecasts

11.3 Average Cost of Vaccination

11.4 Immunization Schedule

11.5 Target Population

11.5.1 Immunization Coverage

11.6 Product Analysis

11.6.1 Gardasil

11.6.2 Cervarix

11.7 Vaccine Pipeline Analysis

12 The Future of Global Vaccines: Global Seasonal Flu Vaccine Market

12.1 Market Overview

12.2 Market Forecasts

12.3 Average Cost of Vaccination

12.4 Immunization Schedule

12.5 Target Population

12.5.1 Immunization Coverage

12.6 Product Analysis

12.7 Vaccine Pipeline Analysis

13 The Future of Global Vaccines: Competitive Landscape

13.1 Overview

13.2 Market Share Analysis

13.3 Competitor Profiles

13.3.1 Sanofi Pasteur MSD

13.3.2 Merck

13.3.3 GlaxoSmithKline (GSK)

13.3.4 Novartis

13.3.5 Pfizer

13.3.6 Sanofi Pasteur

14 The Future of Global Vaccines: Strategic Consolidations

14.1 Mergers and Acquisitions

14.2 Licensing Agreements

15 Appendix

15.1 Market Definitions

15.2 Key Support Data

15.3 Abbreviations

15.4 Methodology

15.4.1 Coverage

15.4.2 Secondary Research

15.4.3 Primary Research

15.4.4 Expert Panel Validation

15.5 Contact Us

15.6 Disclaimer

List of Tables

Table 1: Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Table 2: Vaccines Market, Global, Market Share by Disease Segment, 2009

Table 3: Vaccines Market, Global, Target Population for Pediatric Vaccines, 2007-2016

Table 4: Vaccines Market, Global, Target Population for Adult Vaccines, 2007-2016

Table 5: Vaccines Market, Global, Immunization Coverage for Key Vaccines, 2007-2009

Table 6: Vaccines Market, The US, Revenue Forecasts ($bn), 2007-2016

Table 7: Vaccines Market, The US, Average Cost of Vaccination Per Child ($), 2009

Table 8: Vaccines Market, Europe, Revenue Forecasts ($bn), 2007-2016

Table 9: Vaccines Market, Europe, Average Cost of Vaccination per Child ($), 2009

Table 10: Vaccines Market, Rest of the World, Revenue Forecasts ($bn), 2007-2016

Table 11: Vaccines Market, Rest of the World, Average Cost of Vaccination per Child ($), 2009

Table 12: Rotavirus Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Table 13: Rotavirus Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Table 14: Rotavirus Vaccines Market, Global, Target Population, 2007-2016

Table 15: Rotavirus Vaccines Market, Global, Comparison of Key Products, 2009

Table 16: Pneumococcal Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Table 17: Pneumococcal Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Table 18: Pneumococcal Vaccines Market, Global, Target Population, 2007-2016

Table 19: Pneumococcal Vaccines Market, Global, Comparison of Key Products, 2009

Table 20: HPV Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Table 21: HPV Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Table 22: HPV Vaccines Market, Global, Target Population, 2007-2016

Table 23: HPV Vaccines Market, Global, Comparison of Key Products, 2009

Table 24: Seasonal Flu Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Table 25: Seasonal Flu Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Table 26: Seasonal Flu Vaccines Market, Global, Target Population, 2007-2016

Table 27: Seasonal Flu Vaccines Market, Global, Comparison of Key Products, 2009

Table 28: Vaccines Market, Global, Top 3 M&A Deals, 2009

Table 29: Vaccines Market, Global, Licensing Deals by Phase, Discovery, 2009

Table 30: Vaccines Market, Global, Licensing Deals by Phase, Phase I, 2009

Table 31: Vaccines Market, Global, Licensing Deals by Phase, Phase II, 2009

Table 32: Vaccines Market, Global, Licensing Deals by Phase, Phase III, 2009

Table 33: Vaccines Market, Global, Licensing Deals by Phase, Filed for Approval, 2009

Table 34: Vaccines Market, Global, Licensing Deals by Phase, Approved, 2009

List of Figures

Figure 1: Vaccines Market, Global, Market Overview, 2009

Figure 2: Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Figure 3: Vaccines Market, Global, Market Share by Disease Segment, 2009

Figure 4: Vaccines Market, Global, Market Share by Geography, 2009

Figure 5: Vaccines Market, Global, Average Cost of Vaccination by Geography, 2009

Figure 6: Vaccines Market, Global, Target Population for Pediatric Vaccines, 2007-2016

Figure 7: Vaccines Market, Global, Target Population for Adult Vaccines, 2007-2016

Figure 8: Vaccines Market, Global, Immunization Coverage for Key Vaccines, 2007-2009

Figure 9: Vaccines Market, Global, Unmet Needs, 2009

Figure 10: Vaccines Market, Global, Drivers and Barriers, 2009-2016

Figure 11: Vaccines Market, The US, Revenue Forecasts ($bn), 2007-2016

Figure 12: Vaccines Market, The US, Average Cost of Vaccination Per Child ($), 2009

Figure 13: Vaccines Market, The US, Immunization Schedule, 2009

Figure 14: Vaccines Market, Europe, Revenue Forecasts ($bn), 2007-2016

Figure 15: Vaccines Market, Europe, Average Cost of Vaccination Per Child ($), 2009

Figure 16: Vaccines Market, The UK, Immunization Schedule, 2009

Figure 17: Vaccines Market, France, Immunization Schedule, 2009

Figure 18: Vaccines Market, Germany, Immunization Schedule, 2009

Figure 19: Vaccines Market, Italy, Immunization Schedule, 2009

Figure 20: Vaccines Market, Spain, Immunization Schedule, 2009

Figure 21: Vaccines Market, Rest of the World, Revenue Forecasts ($bn), 2007-2016

Figure 22: Vaccines Market, Rest of the World, Average Cost of Vaccination Per Child ($), 2009

Figure 23: Rotavirus Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Figure 24: Rotavirus Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Figure 25: Rotavirus Vaccines Market, Global, Target Population, 2007-2016

Figure 26: Pneumococcal Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Figure 27: Pneumococcal Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Figure 28: Pneumococcal Vaccines Market, Global, Target Population, 2007-2016

Figure 29: HPV Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Figure 30: HPV Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Figure 31: HPV Vaccines Market, Global, Target Population, 2007-2016

Figure 32: Seasonal Flu Vaccines Market, The US, Doses Produced and Distributed, 2000-2008

Figure 33: Seasonal Flu Vaccines Market, The US, Sales by Channel, 2008

Figure 34: Seasonal Flu Vaccines Market, The US, Production Share by Company, 2008

Figure 35: Seasonal Flu Vaccines Market, The US, Market Share by Provider Type, 2007

Figure 36: Seasonal Flu Vaccines Market, The US, Dose Volume (million), 2009

Figure 37: Seasonal Flu Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016

Figure 38: Seasonal Flu Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016

Figure 39: Seasonal Flu Vaccines Market, Global, Target Population, 2007-2016

Figure 40: Vaccines Market, Global, Market Share by Company, 2009

Figure 41: Vaccines Market, Global, Comparison of Competitor Revenues by Quarter ($m), 2009

Figure 42: Vaccines Market, Global, Competitive Benchmarking of Top Six Vaccine Players, 2009-2016

Figure 43: Vaccines Market, Global, Competitive Benchmarking of Key Vaccine Markets, 2009-2016

Figure 44: Vaccines Market, Global, Sanofi Pasteur MSD, Sales of Key Product Segments by Quarter, 2009

Figure 45: Vaccines Market, Global, Merck, Sales of Key Product Segments by Quarter, 2009

Figure 46: Vaccines Market, Global, GlaxoSmithKline, Sales of Key Product Segments by Quarter, 2009

Figure 47: Vaccines Market, Global, Novartis, Sales of Key Product Segments by Quarter, 2009

Figure 48: Vaccines Market, Global, Sanofi Pasteur, Sales of Key Product Segments by Quarter, 2009

Figure 49: Vaccines Market, Global, M&A Landscape by Deal Type, 2009

Figure 50: Vaccines Market, Global, M&A Deals by Geography, 2009

Figure 51: Vaccines Market, Global, M&A Deals by Value, 2009

Figure 52: Vaccines Market, Global, Licensing & Alliances by Phase, 2009

Figure 53: Vaccines Market, Global, Licensing & Alliances Geography, 2009

Figure 54: Vaccines Market, Global, Licensing & Alliances by Deal Value, 2009

Figure 55: Vaccines Market, Global, Licensing & Alliances by Indications, 2009

Figure 56: GBI Research Methodology

Companies mentioned

Sanofi Pasteur MSD

Merck

GlaxoSmithKline (GSK)

Novartis

Pfizer

Sanofi Pasteur

To order this report:

Pharmaceutical Industry: The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis

More Market Research Report

-- Annualized market data for the global vaccines market from 2000 to 2008, forecast forward to 2015. -- Analysis of the metabolic disorder therapeutics market in the leading geographies of the world. This includes the US, the UK, Germany, France, Italy, Spain, and Japan -- Market characterization data on the global vaccines market including market size, market share and annual cost of vaccination. -- Key drivers and restraints that have a significant impact on the market -- Competitive landscape of the global vaccines market. The key companies studied in this report are Novartis AG, Sanofi Pasteur, Merck & Co, GlaxoSmithKline and Pfizer Inc. -- Key M&A activities and licensing agreements that have taken place between 2008 and 2009 in the global vaccines market.

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds The Future of the Pharmaceutical...
S
Reportlinker Adds The Future of Biosimilars - Mar...